Preparation and characterization of a new bio nanocomposites based poly(glycerol sebacic-urethane) containing nano-clay (Cloisite Na+ ) and its potential application for tissue engineering.

Nanocomposites containing clay nanoparticles often present favorable properties such as good mechanical and thermal properties. They frequently have been studied for tissue engineering (TE) and regenerative medicine applications. On the other hand, poly(glycerol sebacate) (PGS), a revolutionary bioelastomer, has exhibited substantial potential as a promising candidate for biomedical application. Here, we present a facile approach to synthesizing stiff, elastomeric nanocomposites from sodium-montmorillonite nano-clay (MMT) in the commercial name of Cloisite Na+ and poly(glycerol sebacate urethane) (PGSU). The strong physical interaction between the intercalated Cloisite Na+ platelets and PGSU chains resulted in desirable property combinations for TE application to follow. The addition of 5% MMT nano-clay resulted in an over two-fold increase in the tensile modulus, increased the onset thermal decomposition temperature of PGSU matrix by 18°C, and noticeably improved storage modulus of the prepared scaffolds, compared with pure PGSU. As well, Cloisite Na+ enhanced the hydrophilicity and water uptake ability of the samples and accelerated the in-vitro biodegradation rate. Finally, in-vitro cell viability assay using L929 mouse fibroblast cells indicated that incorporating Cloisite Na+ nanoparticles into the PGSU network could improve the cell attachment and proliferation, rendering the synthesized bioelastomers potentially suitable for TE and regenerative medicine applications.

Optimization of Ni(II) adsorption onto Cloisite Na+ clay using response surface methodology.

The aim of this study was to investigate the adsorption of Ni(II) from aqueous solutions onto Cloisite Na+ clay. The effects of the initial concentration of Ni(II), adsorbent dose, pH, and temperature on adsorption capacity were studied using response surface methodology. A second-order regression model was determined based on the experimental results. Analysis of variance used to evaluate the individual and combined effects of process variables showed that initial Ni(II) concentration and adsorbent dose were more significant than solution pH and temperature. Moreover, the interaction effects of the initial concentration of nickel and the adsorbent dose, as well as the solution pH and adsorbent dose were significant. High coefficient of determination (R2 = 0.93) and low probability values signify the validity of the model for predicting the adsorption capacity of Cloisite Na+ for Ni(II) ions. The optimal conditions for pH and adsorbent dose were found to be 6.9 and 0.21 g/L, respectively at a constant temperature of 25 °C and initial Ni(II) concentration of 50 mg/L. Under these conditions, the adsorption capacity of clay was found to be 31.43 mg/g. Moreover, the adsorption isotherms results indicated that these data could be best fitted to the Langmuir isotherm model (R2 = 0.99). The Langmuir maximum adsorption capacity was estimated to be 32.05 mg/g for an adsorbent dose of 0.2 g/L at pH 7 and 25 °C. In conclusion, the results showed that Cloisite Na+ clay can be utilized as an effective adsorbent for the removal of Ni(II) from aqueous solutions.

Genotoxic potential of montmorillonite clay mineral and alteration in the expression of genes involved in toxicity mechanisms in the human hepatoma cell line HepG2.

Montmorillonite, also known as Cloisite(®)Na(+) (CNa(+)), is a natural clay with a wide range of well-documented and novel applications, such as pharmaceutical products or food packaging. Although considered a low toxic product, the expected increased exposure to CNa(+) arises concern on the potential consequences on human and environmental health especially as its genotoxicity has scarcely been investigated so far. Thus, we investigated, for the first time, the influence of non-cytotoxic concentrations of CNa(+) (15.65, 31.25 and 62.5 µg/mL) on genomic instability of human hepatoma cell line (HepG2) by determining the formation of micronuclei (MNi), nucleoplasmic bridges (NPBs) and nuclear buds (NBUDs) with the Cytokinesis block micronucleus cytome assay. Further on we studied the influence of CNa(+) on the expression of several genes involved in toxicity mechanisms using the real-time quantitative PCR. The results showed that CNa(+) increased the number of MNi, while the numbers of NBUDs and NPBs were not affected. In addition it deregulated genes in all the groups studied, mainly after longer time of exposure. These findings provide the evidence that CNa(+) is potentially genotoxic. Therefore further studies that will elucidate the molecular mechanisms involved in toxic activity of CNa(+) are needed for hazard identification and human safety assessment.

Preparation of new fluorophore lanthanide complexes-Cloisite nanohybrids using the tricationic Pr(III), Gd(III) and Dy(III) complexes with 9,10-phenanthrenequinone.

New fluorophore lanthanide complexes-Cloisite (LCs-C) nanohybrids have been prepared by the intercalation reaction of Cloisite Na(+) with the tricationic lanthanide complexes (1-3), [M(PQ)3(DMF)2(H2O)2](3+) (M=Pr(III) (1), Gd(III) (2), and Dy(III) (3); PQ=9,10-phenanthrenequinone), in aqueous solutions. The X-ray diffraction analysis of the modified clays (LCs-C) showed an increase in the interlayer distance (d) as compared to the pure Cloisite Na(+). Field-emission scanning electron microscopy (FE-SEM) was used to study the morphology of the modified clays and the results were demonstrated a homogeneous morphology for the nanohybrids. The thermal behavior of the LCs-C nanohybrids was investigated using thermogravimetric analysis. Solid-state fluorescence properties of the LCs-C nanohybrids were also investigated. The results show that all tricationic complexes have a significant fluorescence at room temperature when the complexes are adsorbed onto Cloisite.